0001640334-19-001041.txt : 20190604 0001640334-19-001041.hdr.sgml : 20190604 20190604164449 ACCESSION NUMBER: 0001640334-19-001041 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190604 DATE AS OF CHANGE: 20190604 EFFECTIVENESS DATE: 20190604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARTELO BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001621221 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 331220924 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-341133 FILM NUMBER: 19877214 BUSINESS ADDRESS: STREET 1: 888 PROSPECT STREET, SUITE 210 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: 760-943-1689 MAIL ADDRESS: STREET 1: 888 PROSPECT STREET, SUITE 210 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: REACTIVE MEDICAL INC. DATE OF NAME CHANGE: 20170207 FORMER COMPANY: FORMER CONFORMED NAME: KNIGHT KNOX DEVELOPMENT CORP. DATE OF NAME CHANGE: 20141001 D 1 primary_doc.xml X0708 D LIVE 0001621221 ARTELO BIOSCIENCES, INC. 888 Prospect Street Suite 210 La Jolla CA CALIFORNIA 92037 760-943-1689 NEVADA None REACTIVE MEDICAL INC. KNIGHT KNOX DEVELOPMENT CORP. Corporation true Gregory Gorgas c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Executive Officer Director Connie Matsui c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Director R. Martin Emanuele c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Director Steven Kelly c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Director Douglas Blayney c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Director Georgia Erbez c/o Artelo Biosciences, Inc. 888 Prospect Street, Suite 210 La Jolla CA CALIFORNIA 92037 Director Other Health Care Decline to Disclose 06b false 2019-01-08 false true true true false 25000 10000000 4192990 5807010 Total Offering Amount includes $3,000,000 new money; $7,000,000 upon exercise of warrants. Total Amount Sold includes $1,257,897 new money; $2,935,093 upon exercise of warrants false 0 40 0 0 0 false ARTELO BIOSCIENCES, INC. /s/ Gregory Gorgas Gregory Gorgas President and Chief Executive Officer 2019-06-04